A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress
Immunity · 2025-03 · 58 (3) · 648-665.e7
DOI: 10.1016/j.immuni.2025.02.013 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, 2025-03. Verfasst von Sara Perrotta und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Pozzilli, Italy. Hauptthemen laut MEDLINE: Hypertension, Spleen, Ventricular Remodeling, Brain. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Hypertensive heart disease (HTN-HD) meaningfully contributes to hypertension morbidity and mortality. Initially established as an adaptive response, HTN-HD progresses toward worsening of left ventricule (LV) function and heart failure (HF). Hypertensive stress elevates sympathetic nervous system (SNS) activity, a negative clinical predictor, and expands macrophages. How they interact in the compensatory phase of HTN-HD is unclear. We report that LV pressure overload recruited a brainstem neural circuit to enhance splenic SNS and induce placental growth factor (PlGF) secretion. During hypertensive stress, PlGF drove the proliferation of self-renewing cardiac resident macrophages (RMs) expressing its receptor neuropilin-1 (NRP1). Inhibition of the splenic neuroimmune axis or ablation of NRP1 in RM hindered the adaptive response to hypertensive stress, leading to HF. In humans, circulating PlGF correlated with cardiac hypertrophy, and failing hearts expressed NRP1 in RMs. Here, we discovered a multiorgan response driving a neural reflex to expand cardiac NRP1+ RM and counteract HF.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Pozzilli, Italy.
- Department of Angiocardioneurology and Translational Medicine, IRCCS Neuromed, Pozzilli, Italy; Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
- Department of Internal and Agricultural Medicine and Centre for Medical Genomics Omicron, Jagiellonian University, Collegium Medicum, Kraków, Poland.
- Toronto General Hospital Research Institute, University Health Network (UHN), Toronto, ON, Canada.
- Department of Cardiac Surgery and Transplantation, Jagiellonian University, Collegium Medicum, Kraków, Poland.
- Department of Molecular Medicine, "Sapienza" University of Rome, Rome, Italy.
Förderung
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Perrotta, S., Carnevale, L., Perrotta, M., Pallante, F., Mikołajczyk, T. P., Fardella, V., Migliaccio, A., Fardella, S., Nejat, S., Kapelak, B., Zonfrilli, A., Pacella, J., Mastroiacovo, F., Carnevale, R., Bain, C., Puhl, S. L., D'Agostino, G., Epelman, S., Guzik, T. J., …, & Carnevale, D. (2025). A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress. Immunity, 58(3), 648-665.e7. https://doi.org/10.1016/j.immuni.2025.02.013
Vancouver
Perrotta S, Carnevale L, Perrotta M, Pallante F, Mikołajczyk TP, Fardella V, et al. A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress. Immunity. 2025;58(3):648-665.e7. doi:10.1016/j.immuni.2025.02.013
BibTeX
@article{Perrotta2025,
author = {Perrotta, Sara and Carnevale, Lorenzo and Perrotta, Marialuisa and Pallante, Fabio and Mikołajczyk, Tomasz P and Fardella, Valentina and Migliaccio, Agnese and Fardella, Stefania and Nejat, Sara and Kapelak, Boguslaw and Zonfrilli, Azzurra and Pacella, Jacopo and Mastroiacovo, Francesco and Carnevale, Raimondo and Bain, Calum and Puhl, Sarah Lena and D'Agostino, Giuseppe and Epelman, Slava and Guzik, Tomasz J and Lembo, Giuseppe and Carnevale, Daniela},
title = {A heart-brain-spleen axis controls cardiac remodeling to hypertensive stress},
journal = {Immunity},
year = {2025},
volume = {58},
number = {3},
pages = {648--665.e7},
doi = {10.1016/j.immuni.2025.02.013}
}
EUVIMED